Search
for
Sort by
Research 631–660 of 696
- PRP therapy in chronic diffuse alopecia areata – A case report
- Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study
- Drug-induced alopecia areata: A systematic review
- Content validity of five single‐item instruments in adolescents with alopecia areata
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- RETRACTED: Causal role of immune cells in alopecia areata: A two‐sample Mendelian randomization study
- Application of Baricitinib in Dermatology
- Intravenous methylprednisolone pulse therapy in severe alopecia areata
- Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Successful Treatment of Alopecia Areata Barbae with Platelet-rich Plasma
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
- A Case Report of the Retreatment with the Same Herbal Medicine after the Treatment of Alopecia Areata in a Child
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Janus kinase inhibitors for alopecia areata: A narrative review
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- Retrospective Study about the Effectiveness of Korean Medical Treatment on 222 Patients with Alopecia Areata
- Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990–2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021
- The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA